Alligator Bioscience AB (ATORX) — Working Capital to Net Assets Ratio
Alligator Bioscience AB (ATORX) has a Working Capital to Net Assets ratio of -138.3% as of December 2025. Working capital of Skr-9.48 Million (current assets of Skr68.66 Million minus current liabilities of Skr78.14 Million) is measured against net assets of Skr6.86 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Alligator Bioscience AB net asset quality index to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Alligator Bioscience AB Working Capital to Net Assets (2011–2025)
This chart shows how Alligator Bioscience AB's Working Capital to Net Assets ratio has evolved across 13 annual periods from 2011 to 2025. As of December 2025, the ratio stands at -138.3%, reflecting working capital of Skr-9.48 Million against net assets of Skr6.86 Million SEK. Check ATORX intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Alligator Bioscience AB (2011–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Alligator Bioscience AB from 2011 to 2025, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Alligator Bioscience AB market capitalisation.
| Year | WC/NA Ratio | Working Capital (SEK) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | -138.3% | Skr-9.48 Million | Skr6.86 Million | Skr68.66 Million | Skr78.14 Million | ▼ -237.8 pp |
| 2024 | 99.6% | Skr-130.06 Million | Skr-130.59 Million | Skr71.40 Million | Skr201.45 Million | ▲ +275.8 pp |
| 2023 | -176.2% | Skr-20.89 Million | Skr11.86 Million | Skr78.19 Million | Skr99.08 Million | ▼ -241.7 pp |
| 2022 | 65.5% | Skr58.28 Million | Skr89.05 Million | Skr122.81 Million | Skr64.53 Million | ▼ -23.9 pp |
| 2021 | 89.3% | Skr252.20 Million | Skr282.27 Million | Skr299.61 Million | Skr47.42 Million | ▲ +20.3 pp |
| 2020 | 69.1% | Skr79.63 Million | Skr115.24 Million | Skr110.34 Million | Skr30.72 Million | ▲ +5.2 pp |
| 2019 | 63.8% | Skr165.05 Million | Skr258.50 Million | Skr205.99 Million | Skr40.94 Million | ▼ -16.8 pp |
| 2018 | 80.7% | Skr377.70 Million | Skr468.31 Million | Skr417.55 Million | Skr39.85 Million | ▼ -1.6 pp |
| 2017 | 82.2% | Skr508.23 Million | Skr617.96 Million | Skr533.31 Million | Skr25.08 Million | ▼ -14.1 pp |
| 2016 | 96.4% | Skr651.58 Million | Skr676.18 Million | Skr676.18 Million | Skr24.59 Million | ▲ +7.9 pp |
| 2015 | 88.5% | Skr351.13 Million | Skr396.97 Million | Skr370.42 Million | Skr19.29 Million | ▲ +70.7 pp |
| 2014 | 17.7% | Skr12.13 Million | Skr68.52 Million | Skr41.41 Million | Skr29.27 Million | ▼ -50.1 pp |
| 2011 | 67.8% | Skr14.58 Million | Skr21.51 Million | Skr23.69 Million | Skr9.11 Million | — |